ViaDerma, Inc. (VDRM)
OTCMKTS · Delayed Price · Currency is USD
0.0016
-0.0001 (-5.88%)
Aug 4, 2025, 3:51 PM EDT

ViaDerma Company Description

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States.

It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas.

The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.

It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management.

The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014.

ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

ViaDerma, Inc.
CountryUnited States
Founded2007
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees75
CEOChristopher Otiko

Contact Details

Address:
4640 Admiralty Way
Marina del Rey, Nevada 90292
United States
Phone310 496 5744
Websiteviaderma.com

Stock Details

Ticker SymbolVDRM
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS92555K1016
SIC Code2834

Key Executives

NamePosition
Dr. Christopher A OtikoFounder, Chief Executive Officer and President
Qing Hua LinChief Financial Officer and Director
Baotang ZhaoChief Sales Officer
Zhang XieCorporate Secretary and Director
Dr. Andrew Berman M.D., MPHMedical Director and Member of Advisory Board